Matches in Harvard for { <http://id.lib.harvard.edu/aleph/003390084/catalog> ?p ?o. }
Showing items 1 to 29 of
29
with 100 items per page.
- catalog contributor b4919517.
- catalog created "1993-".
- catalog date "1993".
- catalog date "1993-".
- catalog dateCopyrighted "1993-".
- catalog description "Includes bibliographical references.".
- catalog description "pt. 1. Washington, DC, March 11, 1993; serial no. 103-5 -- pt. 2. Washington, DC, June 17, 1993; serial no. 103-25.".
- catalog extent "v. :".
- catalog hasFormat "Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry.".
- catalog identifier "0160412811 (pt. 1)".
- catalog identifier "0160416779 (pt. 2)".
- catalog isFormatOf "Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry.".
- catalog issued "1993".
- catalog issued "1993-".
- catalog language "eng".
- catalog publisher "Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,".
- catalog relation "Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry.".
- catalog spatial "United States".
- catalog spatial "United States.".
- catalog subject "Conflict of interests United States.".
- catalog subject "Drug development Government policy United States.".
- catalog subject "Drugs Research Government policy United States.".
- catalog subject "Drugs United States Patents.".
- catalog subject "KF27 .S675 1993e".
- catalog subject "Pharmaceutical industry Government policy United States.".
- catalog subject "Research and development contracts, Government United States.".
- catalog tableOfContents "pt. 1. Washington, DC, March 11, 1993; serial no. 103-5 -- pt. 2. Washington, DC, June 17, 1993; serial no. 103-25.".
- catalog title "Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.".
- catalog type "text".